Contera Pharma, Bukwang Pharm's subsidiary in Denmark, announced on Dec. 19 that it has recently opened a new research center at its research center in DTU Science Park in Hørsholm, north of Copenhagen, Denmark.Contera Pharma is a Danish biotech startup specializing in central nervous system dis
The Federation of Korean Industries recently conducted a survey at 150 companies in the top 12 export industries of South Korea and on the top 1,000 list in terms of sales. When it comes to South Korea’s 2023 export growth rate, their average estimate is 0.5 percent. For reference, the rate was 25.7
SK Inc., the holding company of SK Group, plans to increase the net asset value (NAV) of the group's green business by 14 times within eight years. The company intends to use the group's efforts to overcome climate change as an opportunity to expand its future business.SK Inc.'s Green In
K-CAB, a new drug within the P-CAB category developed by HK inno.N for the treatment of GERD, has a 27 percent lower risk of hepatotoxicity compared with other treatments, HK inno.N said, citing a study conducted by a Korean scholar.The study, undertaken by Professor Kim Jeong-seung of the Ear, Nose
The Korea International Trade Association (KITA) announced on Dec. 4 that South Korea’s exports are expected to reach an all-time high of US$690 billion this year. The previous high is US$644.4 billion, which was recorded last year. The monthly exports have topped US$50 billion for 20 months in a ro
The authors are analysts of Shinhan Securities. They can be reached at shawn1225@shinhan.com and jhwon@shinhan.com, respectively. – Ed. US partner Spectrum receives CRL from FDA for poziotinibSpectrum Pharmaceuticals, Hanmi Pharm’s US partner for the non-small cell lung cancer treatment candidate po
The authors are analysts of Shinhan Securities. They can be reached at sehunjang@shinhan.com and shawn1225@shinhan.com, respectively. -- Ed. Time to price in the value of next-generation FcRn inhibitorHanall Biopharma’s recent share price trend suggests that the removal of uncertainty in the clinica
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. In 2022, healthcare stocks have been performing sluggishly in the NY stock market, affected by drastic absorption of market liquidity since early-2022. Given that 10-yr discounted cash flow is the mo
The Korea Institute for Industrial Economics and Trade said in its report on Nov. 21 that the South Korean economy is estimated to grow 1.9 percent next year.“South Korea’s annual exports are estimated to decrease 3.1 percent next year with demand contraction and deteriorating semiconductor industry
The Korea Enterprises Federation has recently conducted a survey at 415 companies in four industries. According to the results, 52.2 percent of South Korean shipbuilders are understaffed and the ratio is 45 percent in the semiconductor industry, 43 percent in future car and 29 percent in biotech and
The author is an analyst of KB Securities. He can be reached at kimtaehee@kbfg.com. -- Ed. Slightly lower target price to KRW350,000 on WACC increase We slightly lower our TP (KRW380,000→KRW350,000) on Hanmi Pharm. While we revise up our earnings estimates to reflect 3Q22 results, we raise RFR to 3.
Aprogen has joined a race to take over a current good manufacturing practice (cGMP) production facility in North Carolina of the United States. The move reflects its strategy to quickly advance into the U.S. market in response to U.S. President Joe Biden’s policy to favor U.S.-made biotech products.
JW Group announced on Nov. 1 that it has signed a joint research contract with KURE.AI Therapeutics, a U.S. biotech venture company, to develop innovative anticancer therapies based on artificial intelligence (AI).Under this contract, JW Pharmaceutical and JW CreaGene will start R&D activities for t
JW Pharmaceutical announced on Oct. 31 that it will make a poster presentation on the results of a preclinical study on JW0061, a Wnt target hair loss treatment, at Wnt 2022, a conference to be held in Japan for five days from Nov. 15.Wnt is an acronym in the field of genetics that stands for 'W
SK Inc.’s pharmaceutical and bio business is growing fast through a steady localization strategy. The company plans to expand its contract development and manufacturing organization (CDMO) business to cover cell and gene therapies (CGTs).SK Pharmteco, a CDMO subsidiary of SK Inc., is expected to rac
KT announced on Oct. 27 that Global AI Conference 2022 was successfully held online on Oct. 26. The conference was hosted by the AI Task Force (AI TF) of the Strategic Cooperation Framework Agreement (SCFA), a consultative body of the three key telecom operators in Korea, China and Japan -- KT of
During the Global MBB Forum 2022, David Wang, Huawei's executive director of the board and chairman of ICT Infrastructure Managing Board delivered a keynote speech titled Stride to 5.5G: The foundation of the future.Wang noted how the industry has made significant progress and is ready to make t
GS Group will take over Medit Corp., a Korean company that produces 3D dental scanners and solutions, for 3 trillion won, jointly with Carlyle Group of the United States.Medit specializes in 3D measurement and CAD/CAM solutions for dental clinics and labs, including intraoral scanners.GS Group is ag
EOFlow Co., a provider of wearable drug delivery systems (DDS), announced on Oct. 24 that it would invest 36.9 billion won in its U.S. subsidiary EOFlow, Inc.The majority of this investment in EOFlow, Inc., approximately 31 billion won, will be used for collecting loans given by EOFlow to its U.S. s
SK bioscience announced on Oct 21 that it has hired Harry Kleanthous, senior program officer of the Bill & Melinda Gates Foundation, as vice president of vaccine R&D strategy and external innovation of SK bioscience USA, its U.S. subsidiary.Kleanthous has served as vice president of Acambis Inc., a